Quarterly report · Q2
6856.TEDINET S100RNOS
Period2023-01-01 → 2023-06-30
Filed2023-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥131.1bn | 2023-01-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥270.1bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥115.0bn | 2022-01-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | ¥17.8bn | 2023-01-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥16.3bn | 2022-01-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥18.1bn | 2023-01-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥46.9bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥16.8bn | 2022-01-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥24.4bn | 2023-01-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥16.8bn | 2022-01-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥19.0bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥34.1bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥11.2bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥19.0bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥11.2bn | 2022-01-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥435.3bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥416.7bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥398.4bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥168.4bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥175.9bn | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥266.8bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥240.8bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥224.6bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥127.7bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥139.9bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥127.0bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥138.8bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥139.3bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥133.9bn | at 2021-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥3.6bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥34.0bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥10.3bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.3bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥10.7bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥3.1bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥18.6bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥22.4bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥6.9bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥449.87 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥128.88 | 2023-04-01 → 2023-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥807.06 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥266.31 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥130.72 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥447.66 | 2023-01-01 → 2023-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥802.89 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥264.93 | 2022-01-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 61.1% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.6% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.2% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E01901-000Automotivereportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥30.5bn |
| jpcrp040300-q2r_E01901-000Automotivereportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥30.5bn |
| jpcrp040300-q2r_E01901-000Automotivereportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥2.2bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥15.6bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥15.6bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥178m |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥11.3bn |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥11.3bn |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥916m |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥17.4bn |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥17.4bn |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥213m |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥56.2bn |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥56.2bn |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥18.7bn |
| jpcrp040300-q2r_E01901-000Automotivereportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥25.7bn |
| jpcrp040300-q2r_E01901-000Automotivereportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥25.7bn |
| jpcrp040300-q2r_E01901-000Automotivereportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥1.8bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥13.7bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥13.7bn |
| jpcrp040300-q2r_E01901-000Medical Diagnosticsreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥162m |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥10.2bn |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥10.2bn |
| jpcrp040300-q2r_E01901-000Process And Environmentalreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥638m |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥16.0bn |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥16.0bn |
| jpcrp040300-q2r_E01901-000Scientificreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥765m |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥49.4bn |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥49.4bn |
| jpcrp040300-q2r_E01901-000Semiconductorreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥16.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 565
| Item | Context | Value | Unit |
|---|---|---|---|
| Short term loans payable | CurrentQuarterInstant | 3016000000 | JPY |
| Accounts payable other | Prior1YearInstant | 19443000000 | JPY |
| Accounts payable other | CurrentQuarterInstant | 18490000000 | JPY |
| Income taxes payable | Prior1YearInstant | 9133000000 | JPY |
| Income taxes payable | CurrentQuarterInstant | 7290000000 | JPY |
| Contract liabilities | Prior1YearInstant | 24632000000 | JPY |
| Contract liabilities | CurrentQuarterInstant | 30056000000 | JPY |
| Provision for bonuses | Prior1YearInstant | 2003000000 | JPY |
| Provision for bonuses | CurrentQuarterInstant | 1158000000 | JPY |
| Provision for directors bonuses | Prior1YearInstant | - | JPY |
| Provision for directors bonuses | CurrentQuarterInstant | 527000000 | JPY |
| Provision for product warranties | Prior1YearInstant | 2799000000 | JPY |
| Provision for product warranties | CurrentQuarterInstant | 3138000000 | JPY |
| Other cl | Prior1YearInstant | 4920000000 | JPY |
| Other cl | CurrentQuarterInstant | 5760000000 | JPY |
| Current liabilities | Prior1YearInstant | 112229000000 | JPY |
| Current liabilities | CurrentQuarterInstant | 103007000000 | JPY |
| Bonds payable | Prior1YearInstant | 30000000000 | JPY |
| Bonds payable | CurrentQuarterInstant | 30000000000 | JPY |
| Long term loans payable | Prior1YearInstant | 24854000000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 24920000000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | 1270000000 | JPY |
| Deferred tax liabilities | CurrentQuarterInstant | 2060000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 1547000000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 1837000000 | JPY |
| Other ncl | Prior1YearInstant | 5990000000 | JPY |
| Other ncl | CurrentQuarterInstant | 6622000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 63663000000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 65440000000 | JPY |
| Liabilities | Prior1YearInstant | 175892000000 | JPY |
| Liabilities | CurrentQuarterInstant | 168448000000 | JPY |
| Capital stock | Prior1YearInstant | 12011000000 | JPY |
| Capital stock | CurrentQuarterInstant | 12011000000 | JPY |
| Capital surplus | Prior1YearInstant | 18684000000 | JPY |
| Capital surplus | CurrentQuarterInstant | 18766000000 | JPY |
| Retained earnings | Prior1YearInstant | 194000000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 205405000000 | JPY |
| Treasury stock | Prior1YearInstant | -1193000000 | JPY |
| Treasury stock | CurrentQuarterInstant | -1037000000 | JPY |
| Shareholders equity | Prior1YearInstant | 223502000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 235145000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 4257000000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 5612000000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 12156000000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 25179000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 148000000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | 150000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 16562000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 30942000000 | JPY |
| Subscription rights to shares | Prior1YearInstant | 769000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |